Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.

about

Modeling chick to assess diabetes pathogenesis and treatment.Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis.

P2860

Q35758475-2842AEAD-47BC-4DEE-AD1F-E1BE9E42A263 Q40778053-A0DD30DF-0512-4C63-85D2-0EEA66CA53CD

P2860

Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.

Item

http://www.wikidata.org/entity/Q36800392

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@ast

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@en

type

Item

label

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@ast

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@en

prefLabel

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@ast

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@en

P1476

Angiogenesis and diabetes: dif ...... horioallantoic membrane assay.

@en

P2093

Antoine Alam

http://www.w3.org/2001/XMLSchema#string

Etienne Larger

http://www.w3.org/2001/XMLSchema#string

Frédéric Dol

http://www.w3.org/2001/XMLSchema#string

Giovana S Di Marco

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Gasc

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes

Angiogenesis in life, disease and medicine

The pathobiology of diabetic complications: a unifying mechanism

Angiogenesis as a therapeutic target

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.

In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications.

Abnormal angiogenesis in diabetes mellitus.

Re-evaluating therapeutic neovascularization.

P2888

2008-00054.dimarco

P304

705-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/2008-00054.DIMARCO

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Corvol

P577

2008-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1068965087

http://www.w3.org/2001/XMLSchema#string

P698

18670619

http://www.w3.org/2001/XMLSchema#string

P932

2491448

http://www.w3.org/2001/XMLSchema#string

Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.

about

P2860

P2860

Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932